Journal: PLoS ONE
Article Title: GPR50 Interacts with TIP60 to Modulate Glucocorticoid Receptor Signalling
doi: 10.1371/journal.pone.0023725
Figure Lengend Snippet: ( A ) RT-PCR profiling of Gpr50 and Tip60 mRNA expression in mouse tissues. Hp, hypothalamus; Pt, pituitary; Ht, heart; Lg, lung; E, eye; Th, thyroid; A, adrenal; F, white fat; T, testes; I, intestine; Lv, liver; K, kidney; Sp, spleen; St, stomach; Pa, pancreas. ( B–E ) The effects of dexamethasone (Dex, 0.1 mg/kg) were examined in WT and Gpr50 −/− mice, in terms of glucocorticoid feedback and glucose homeostasis. Pomc mRNA expression in the pituitary was reduced 5 hr after Dex treatment in WT, but not Gpr50 −/− mice ( B ). Circulating blood glucose was significantly increased in response to Dex only in WT mice ( C ). Similarly, Gpr50 −/− mice exhibited an attenuated induction of the liver gluconeogenic genes Pepck ( D ) and Tat ( E ) in response to Dex. Gene expression has been normalised to vehicle treated levels, and blood glucose presented as change from time 0 to 5 h post-injection. * = P<0.05, ** = P<0.01 versus vehicle treatment within genotype, # = P<0.05 versus WT Dex treatment, two-way ANOVA with Bonferroni's post hoc test. Data representative of two independent experiments n = 5 mice/group in each experiment for B–D .
Article Snippet: The correct sequences and reading frames of all constructs derived from PCR products were verified by DNA sequencing. shRNA against Gpr50 was purchased from Sigma ( CCGGGCCAGCTCTAATCATCTTCATCTCGAGATGAAGATGATTAGAGCTGGCTTTTT , TRCN0000025780).
Techniques: Reverse Transcription Polymerase Chain Reaction, Expressing, Injection